ReviewOncology reports2026

<p>Immunotherapy after EGFR‑TKI treatment in advanced non‑small cell lung cancer: Current status and future perspectives (Review)</p>.

Huiyuan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.